THE GENETIC-DEFECT OF MEPHENYTOIN HYDROXYLATION

被引：28

作者：

KALOW, W

机构：

来源：

XENOBIOTICA | 1986年 / 16卷 / 05期

关键词：

D O I：

10.3109/00498258609050246

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：379 / 389

页数：11

共 36 条

[1]

ASLANIAN W, 1983, PHARMACOLOGIST, V25, P218

[2] THE INHIBITORY EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON HEPATIC MICROSOMAL-ENZYME SYSTEMS OF RAT-LIVER [J].

BELANGER, PM ;

ATITSEGBEASSOR, A .

PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (09) :819-828

[3]

BUTLER TC, 1954, J PHARMACOL EXP THER, V110, P120

[4]

BUTLER TC, 1952, J PHARMACOL EXP THER, V104, P299

[5]

BUTLER TC, 1956, J PHARMACOL EXP THER, V117, P160

[6] IMPAIRMENT OF PHENYTOIN PARA-HYDROXYLATION AS A CAUSE OF SEVERE INTOXICATION [J].

DEWOLFF, FA ;

VERMEIJ, P ;

FERRARI, MD ;

BURUMA, OJS ;

BREIMER, DD .

THERAPEUTIC DRUG MONITORING, 1983, 5 (02) :213-215

[7] MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS [J].

INABA, T ;

JURIMA, M ;

NAKANO, M ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :670-676

[8] A HUMAN CYTOCHROME-P-450 CHARACTERIZED BY INHIBITION STUDIES AS THE SPARTEINE DEBRISOQUINE MONOOXYGENASE [J].

INABA, T ;

NAKANO, M ;

OTTON, SV ;

MAHON, WA ;

KALOW, W .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (07) :860-862

[9]

INABA T, 1985, DRUG METAB DISPOS, V13, P443

[10] SPARTEINE OXIDATION BY THE HUMAN-LIVER - ABSENCE OF INHIBITION BY MEPHENYTOIN [J].

JURIMA, M ;

INABA, T ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (03) :426-428

← 1 2 3 4 →